Vimarsana
Biggest News Aggregation in the World

Valvular Heart News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Valvular Heart. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Valvular Heart Today - Breaking & Trending Today

Valvular Heart Disease: What Your Patients Should Know - Vimarsana News

Valvular Heart Disease: What Your Patients Should Know

What should patients know about valvular heart disease, the forms it can take, how to detect it, and how it is treated?

China TAVR & TMV Market Growth Forecast Report 2022: TAVR Market Forecast to Show CAGR of 55.5% During 2002-2026, with TMV Market Forecast for CAGR of 147% - Vimarsana News

China TAVR & TMV Market Growth Forecast Report 2022: TAVR Market Forecast to Show CAGR of 55.5% During 2002-2026, with TMV Market Forecast for CAGR of 147%

/PRNewswire/ -- The "China TAVR & TMV Market: Insights & Forecast (2022-2026)" report has been added to ResearchAndMarkets.com's offering. The Chinese TAVR...

China TAVR & TMV Market Growth Forecast Report 2022: TAVR Market Forecast to Show CAGR of 55.5% During 2002-2026, with TMV Market Forecast for CAGR of 147% - Vimarsana News

China TAVR & TMV Market Growth Forecast Report 2022: TAVR Market Forecast to Show CAGR of 55.5% During 2002-2026, with TMV Market Forecast for CAGR of 147%

/PRNewswire/ -- The "China TAVR & TMV Market: Insights & Forecast (2022-2026)" report has been added to ResearchAndMarkets.com's offering. The Chinese TAVR...

When shortness of breath could signal you have heart problems - Vimarsana News

When shortness of breath could signal you have heart problems

If you're having trouble breathing, there are many things that could be wrong with your heart. It could happen all at once or over time. It can also

Source: revyuh.com
Lean Antithrombotic Regimen Recommended After TAVI - Vimarsana News

Lean Antithrombotic Regimen Recommended After TAVI

April 12, 2021 Physicians should aim to use the least amount of antithrombotic therapy as possible in their patients undergoing TAVI, according to a new European consensus statement. In general, over the long term, patients should be on monotherapy with an oral anticoagulant if they have an indication for it—like atrial fibrillation (AF)—or with low-dose aspirin if they don’t, according to a group led by Jurriën ten Berg, MD, PhD (St. Antonius Hospital, Nieuwegein, the Netherlands). They advise some type of dual therapy in the first 1 to 6 months for patients who have undergone recent ...

Source: tctmd.com